Cpl Life Sciences US

US Staffing within Life Sciences

Close
  • Job Search
    • Physicians
    • Clinical Research
    • Regulatory Affairs
    • Send us your Resume
  • About Us
    • Meet The Team
    • Testimonials
    • Press
    • Contact Us
  • Industry Training
  • Client Services
    • Testimonials
  • Case Studies
  • My Account
Menu

Pharmaceutical

Written by Cpl Life Sciences US
July 12, 2019

Trump vows action on “Favoured nation” drug price clause

President Donald Trump is preparing an executive order outlining a “favoured nations clause”, where US prices will reflect those in the country paying the least for their medicines. Trump recently made the announcement in a press briefing outside the White House, more than two years after promises to tackle high drug prices had been a

Continue Reading

Written by Cpl Life Sciences US
May 9, 2019

Drug Prices Will Soon Appear in Many TV Ads

The Trump administration for the first time will require pharmaceutical companies to include the price of prescription drugs in television advertisements if the cost exceeds $35 per month. Announced on Wednesday by Alex M. Azar II, the health and human services secretary, it is the most visible action the administration has taken so far to

Continue Reading

Written by Cpl Life Sciences US
March 27, 2019

Thermo Fisher goes into gene therapy manufacturing with $1.7B deal for Brammer

With gene therapies becoming a hot growth area, CDMOs are figuring out how to get a bigger piece of the market. Thermo Fisher Scientific decided to buy its way in, agreeing to pay $1.7 billion to get viral vector producer Brammer Bio. The cash deal, slated to close by the end of the second quarter, will see Waltham,

Continue Reading

Written by Cpl Life Sciences US
November 9, 2018

Democrats look to tackle drug prices after victory

Drug companies could come under increased pressure to lower prices in the US, after the opposition Democrat party won control over the lower house in midterm elections. All the seats in the House of Representatives and a third of the seats in the Senate were up for grabs in the vote seen as a referendum

Continue Reading

Written by Cpl Life Sciences US
September 6, 2018

As Brexit costs mount, Pfizer estimates $100M to adapt its supply chain

In a quarterly filing, the New York-based Big Pharma player said that its “preparations are well advanced to make the changes necessary to meet EU legal requirements after the U.K. is no longer a member state, especially in the regulatory, manufacturing and supply chain areas,” so that it can ensure a continuity of supply in

Continue Reading

Categories

  • Uncategorized
  • News
  • Career Advice
  • Company Info
  • Industry news

Tags

Abbvie achillion acquisitions advertising Alexion Allergan AstraZeneca Biosimilar Biotech BMS Boehringer Ingelheim Boston Breast Cancer Brexit clinical research Clinical Trial clinical trials CMO Conference CPL Physicians Diabetes drug development Elections Eli Lilly FDA Gene therapy Gilead graduate academy Hep C immuno-oncology J&J JnJ Networking Novartis Novo Nordisk oncology Parexel Pfizer Pharmaceutical Regulatory Roche Sandoz Sanofi Takeda US

Like to Talk to a Consultant?

Call or email us directly and find out your next career step:
info@cplphysicians.com or (617) 844-1434



Part of the Cpl Group

Expert Life Science Staffing

Contact Us

Call or email us to find out how we can assist you today

Call Us

Email Us

Our Offices

HEADQUARTERS
Cambridge, Boston,
Call: (617) 844-1434

UK
T: +44 (0)118 9522 799
BELGIUM
T: +32 (0)2 892 3993
GERMANY
T: +49 (0)711 222 54 403
IRELAND
T: +353 (0)144 752 96

© 2017 CPL Physicians — All Rights Reserved
Linked In Twitter Google
Back to Top